Vitamin D Receptor: A Novel Therapeutic Target for Kidney Diseases

Author(s): Shikun Yang, Aimei Li, JianWen Wang, Jun Liu, Yachun Han, Wei Zhang, Yan Chun Li, Hao Zhang*.

Journal Name: Current Medicinal Chemistry

Volume 25 , Issue 27 , 2018

  Journal Home
Translate in Chinese

Abstract:

Background: Kidney disease is a serious problem that adversely affects human health, but critical knowledge is lacking on how to effectively treat established chronic kidney disease. Mounting evidence from animal and clinical studies has suggested that Vitamin D Receptor (VDR) activation has beneficial effects on various renal diseases.

Methods: A structured search of published research literature regarding VDR structure and function, VDR in various renal diseases (e.g., IgA nephropathy, idiopathic nephrotic syndrome, renal cell carcinoma, diabetic nephropathy, lupus nephritis) and therapies targeting VDR was performed for several databases.

Result: Included in this study are the results from 177 published research articles. Evidence from these papers indicates that VDR activation is involved in the protection against renal injury in kidney diseases by a variety of mechanisms, including suppression of RAS activation, anti-inflammation, inhibiting renal fibrogenesis, restoring mitochondrial function, suppression of autoimmunity and renal cell apoptosis.

Conclusion: VDR offers an attractive druggable target for renal diseases. Increasing our understanding of VDR in the kidney is a fertile area of research and may provide effective weapons in the fight against kidney diseases.

Keywords: Vitamin D receptor, renal injury, renal tubular epithelial cell, chronic kidney disease, renal osteodystrophy , Acute kidney injury.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 25
ISSUE: 27
Year: 2018
Page: [3256 - 3271]
Pages: 16
DOI: 10.2174/0929867325666180214122352

Article Metrics

PDF: 32
HTML: 2
EPUB: 1